Improving anticoagulation management at the point of care.
Many physicians and other providers attempt therapeutic warfarin oversight without regularly scheduled anticoagulation appointments. Studies show that the risk of major bleeding or thromboembolic events due to warfarin therapy is between 2 percent and 12 percent per year. Point-of-care anticoagulation devices are convenient for patients and physicians and allow for patient-focused anticoagulation care.
Caffee
Anne E
AE
Bernard J. Dunn School of Pharmacy, Shenandoah University in Winchester, Va., USA.
Teichman
Peter G
PG
D000925:Anticoagulants / Q000008:administration & dosage*; D016903:Drug Monitoring / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D019095:Point-of-Care Systems; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014859:Warfarin